These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6196689)

  • 1. [Asymptomatic electrocardiographic abnormalities during antiblastic chemotherapy].
    Bottoni P; Bobba L; Ranieri MG; Croce M; Zaietta P; Provera F
    Minerva Med; 1983 Oct; 74(38):2211-8. PubMed ID: 6196689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternating cyclical hormonal-cytotoxic combination chemotherapy in postmenopausal patients with breast cancer. An EORTC trial.
    Heuson JC; Sylvester R; Engelsman E
    Eur J Cancer (1965); 1980; Suppl 1():113-7. PubMed ID: 7032920
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of several different methods of antiblastic therapy in advanced carcinomas of the digestive system].
    Missale G; Cocconi G; Pettenati V
    Cancro; 1974; 27(1):3-14. PubMed ID: 4136011
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Electrocardiographic study in leukemic children in relation to the antiblastic therapy].
    Pelargonio S; Siccardi M; Paone FM
    Boll Soc Ital Cardiol; 1978; 23(5):959-68. PubMed ID: 95545
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.
    Cavalli F; Alberto P; Jungi F; Brunner K; Martz G
    Eur J Cancer (1965); 1980; Suppl 1():125-9. PubMed ID: 7032922
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combined cytostatic treatment of solid tumours with cyclophosphamide (Endoxan), vincristine, methylaminopterin (Methotrexate) and 5-fluorouracil].
    Brincker H
    Ugeskr Laeger; 1971 May; 133(19):926-9. PubMed ID: 5559763
    [No Abstract]   [Full Text] [Related]  

  • 8. Study on the sensitivity test of carcinostatic agents by acid phosphatase activity.
    Imaizumi M
    Nagoya J Med Sci; 1972 Mar; 34(4):315-33. PubMed ID: 4665966
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant chemotherapy with four drugs for stage 2 breast cancer.
    Wheeler TK; Edelstyn GA; Bates TS; Brinkley D; Evans RG; Kitchen G; MacRae KD; Nicol NT; Spittle M; Wheeler TK
    Eur J Cancer (1965); 1980; Suppl 1():161-3. PubMed ID: 7032926
    [No Abstract]   [Full Text] [Related]  

  • 10. Surgical adjuvant trials in the United States.
    Rozencweig M; Von Hoff DD; Allegra JC; Muggia FM
    Eur J Cancer (1965); 1980; Suppl 1():173-7. PubMed ID: 7032929
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prospective randomized trial on the efficacy of adjuvant endocrine therapy for ER-positive breast cancer patients after radical mastectomy].
    Jiang Z; Song S; Liu X
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):420-2. PubMed ID: 11810777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new six-drug antiblastic regimen (R 14) at low doses (micropolychemotherapy) compared to CMF in the treatment of metastatic breast cancer: phase III study.
    Pannuti F; Iafelice G; Martoni A; Fruet F; Angelelli B; Casadei M
    Chemioterapia; 1984 Aug; 3(4):216-9. PubMed ID: 6398121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group.
    Kaufmann M; Graf E; Jonat W; Eiermann W; Geberth M; Albert US; Gademann G; Conrad B; Stahl K; von Minckwitz G; Schumacher M;
    J Clin Oncol; 2005 Nov; 23(31):7842-8. PubMed ID: 16258087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of antiblastic polychemotherapy (CMF) on the number of circulating monocytes in patients with breast cancer].
    Bariani L; Dolcetti U; Indelli M; Gualandi G; Malacarne P; Castaldi G
    Minerva Med; 1982 Oct; 73(39):2641-8. PubMed ID: 7121879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial.
    Mouridsen HT; Palshof T; Engelsman E; Sylvester R
    Eur J Cancer (1965); 1980; Suppl 1():119-23. PubMed ID: 7032921
    [No Abstract]   [Full Text] [Related]  

  • 16. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV; Bartolucci AA
    Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract]   [Full Text] [Related]  

  • 17. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)].
    Michlmayr G; Kratzer H; Denz H; Huber H
    Wien Klin Wochenschr; 1981 Mar; 93(6):205-7. PubMed ID: 7281697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer 1984: state of the art.
    Sledge GW
    Indiana Med; 1984 Dec; 77(12):935-9. PubMed ID: 6394645
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cooper's combination chemotherapy of metastasizing breast carcinoms].
    van Kaick G; Drings P; Fritsch H; Moskwa G
    Verh Dtsch Ges Inn Med; 1973; 79():1371-3. PubMed ID: 4790187
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chemotherapy of inoperable cancer of the stomach].
    Raevskiĭ IG
    Sov Med; 1974 Oct; (10):30-5. PubMed ID: 4428239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.